Outcome of patients with nonspecific pleuritis at thoracoscopy

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 4, 2011, Pages 242-246

  Wrightson, John M ^a,b   Davies, Helen E ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

idiopathic pleuritis; nonspecific pleuritis; pleural diseases; pleural effusion

Indexed keywords

CALRETININ; CYTOKERATIN 5; CYTOKERATIN 6; MESOTHELIN; PROTEIN; UNCLASSIFIED DRUG; WT 1 PROTEIN;

ADENOCARCINOMA; ADHESION; AMYLOIDOSIS; ANOREXIA; AUTOFLUORESCENCE IMAGING; AUTOFLUORESCENCE THORACOSCOPY; CANCER CELL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CYTOLOGY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOGRAPHY; EMPYEMA; FALSE NEGATIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IDIOPATHIC DISEASE; IDIOPATHIC PLEURITIS; IMMUNOHISTOCHEMISTRY; MESOTHELIAL HYPERPLASIA; MESOTHELIOMA; MESOTHELIUM CELL; NEEDLE BIOPSY; NONSPECIFIC PLEURITIS; PLEURA BIOPSY; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; PLEURODESIS; REVIEW; SENSITIVITY AND SPECIFICITY; THORACOSCOPY; THORACOTOMY; THORAX PAIN; TUBERCULOSIS; TUBERCULOUS PLEURISY; VIDEO ASSISTED THORACOSCOPIC SURGERY; WATCHFUL WAITING; WEIGHT REDUCTION;

HUMANS; PLEURISY; PROGNOSIS; THORACOSCOPY;

EID: 79958781989     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283470293     Document Type: Review

References (22)

1. Wrightson JM, Fysh E, Maskell NA, Lee YC. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med 2010; 16:340-350.
2. Wrightson JM, Helm EJ, Rahman NM, et al. Pleural procedures and pleuroscopy. Respirology 2009; 14:796-807.
3. Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361:1326-1330. (Pubitemid 36514864)
4. Prakash UB, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60:158-164. (Pubitemid 15139121)
5. Renshaw AA, Dean BR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111:106-109. (Pubitemid 27043616)
6. Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii4-ii17. Latest evidence-based pleural disease guidelines, published by British Thoracic Society, describing optimal investigation of unilateral pleural effusions.
7. Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii54-ii60. Latest evidence-based pleural disease guidelines, published by British Thoracic Society, describing indications, technique, yield and complications of medical thoracoscopy/pleuroscopy.
8. Blanc FX, Atassi K, Bignon J, Housset B. Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study. Chest 2002; 121:1677-1683. (Pubitemid 34499687)
9. Ferrer JS, Munoz XG, Orriols RM, et al. Evolution of idiopathic pleural effusion: a prospective, long-term follow-up study. Chest 1996; 109:1508-1513.
10. Hansen M, Faurschou P, Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med 1998; 92:228-232. (Pubitemid 28116244)
11. Allen TC, Cagle PT. Pathology: histology. In: Light RW, Lee YCG, editors. Textbook of pleural diseases. 2nd ed. London, UK: Hodder Arnold; 2008. pp. 285-291.
12. Davies HE, Nicholson JE, Rahman NM, et al. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010; 38:472-477. Recent data describing long-term follow-up of patients with NSP, including eventual diagnoses and possible predictors of 'false-negative' biopsies.
13. Leslie WK, Kinasewitz GT. Clinical characteristics of the patient with non-specific pleuritis. Chest 1988; 94:603-608.
14. Ryan CJ, Rodgers RF, Unni KK, Hepper NG. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981; 56:145-149. (Pubitemid 11002184)
15. Janssen JP, Ramlal S, Mravunac M. The long-term follow up of exudative pleural effusion after nondiagnostic thoracoscopy. J Bronchol 2004; 11:169-174. (Pubitemid 39031222)
16. Venekamp LN, Velkeniers B, Noppen M. Does 'idiopathic pleuritis' exist? Natural history of nonspecific pleuritis diagnosed after thoracoscopy. Respiration 2005; 72:74-78.
17. Husain AN, Colby TV, Ordonez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133:1317-1331. Consensus statement highlighting histological difficulties in diagnosing mesothelioma.
18. McCaughey WT. The diagnosis of mesothelioma by panels. Am J Indus Med 1991; 19:121-124.
19. Chrysanthidis MG, Janssen JP. Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results. Eur Respir J 2005; 26:989-992. (Pubitemid 41829927)
20. Davies HE, Sadler RS, Bielsa S, et al. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009; 180:437-444.
21. Robinson BW, Creaney J, Lake R, et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 2003; 362:1612-1616. (Pubitemid 37443528)
22. Scherpereel A, Lee YC. Biomarkers for mesothelioma. Curr Opin Pulm Med 2007; 13:339-443.